Arvinas

$23.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.41 (-1.72%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell Arvinas and other stocks, options, and ETFs commission-free!

About ARVN

Arvinas, Inc. Common Stock, also called Arvinas, is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110 and ARV-471. The company was founded in February 2013 and is headquartered in New Haven, CT. The listed name for ARVN is Arvinas, Inc. Common Stock.

CEO
John G. Houston
Employees
133
Headquarters
New Haven, Connecticut
Founded
2013
Market Cap
950.06M
Price-Earnings Ratio
Dividend Yield
Average Volume
846.31K
High Today
$23.86
Low Today
$23.31
Open Price
$23.77
Volume
336.87K
52 Week High
$61.57
52 Week Low
$19.68

Collections

ARVN Earnings

-$0.79
-$0.46
-$0.12
$0.21
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 16, Pre-Market

You May Also Like